David Rolfe (Trades, Portfolio) recently submitted the 13F filing for the second quarter of 2025, providing insights int ...

Zoetis’ second quarter saw revenue and adjusted earnings surpass Wall Street expectations, but the market responded ...

Zoetis stock reversed Tuesday, sinking into the red, despite beating second-quarter expectations as Librela sales continued ...

Animal health company Zoetis (NYSE:ZTS) reported in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company ...

The reality is that people and animals will always need medicine, treatments, and other products to live long and comfortable ...

Zoetis raised annual forecast and beat second-quarter estimates on Tuesday, driven by strong demand for its medicines and ...

From supporting identification of certain cell characteristics to complementing clinical expertise with remote pathologist ...

Finally, Zoetis is a dividend-paying stock, with a recent dividend yield of 1.3%. That may not seem like much, but the total annual payout, recently $1.93 per share, is up from $1.30 in 2022 and ...

Meanwhile, the company has an impeccable dividend program. The company has increased its payouts by 502% over the past decade ...

Zoetis Inc. (NYSE:ZTS) today announced that it has agreed to sell $1.850 billion of senior notes, consisting of $850.0 million aggregate principal amount of 4.150% senior notes due 2028 and $1.0 ...

Zoetis Inc - Ordinary Shares - Class A News 7 Agriculture Stocks and ETFs to Buy Demand for food and agriculture products is high and growing fast. Here are 7 investments to buy now.

Zoetis has been growing at a solid pace (~10% per year), and this will be the case for the foreseeable future. A steadily growing pet and livestock healthcare market will bring a nice tailwind.